Literature DB >> 21211989

Gene expression profile of cytokines in patients with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with reduced conditioning.

Antonella Poloni1, Davide Sartini, Monica Emanuelli, Silvia Trappolini, Stefania Mancini, Valentina Pozzi, Benedetta Costantini, Federica Serrani, Eleonora Berardinelli, Elisabetta Renzi, Attilio Olivieri, Pietro Leoni.   

Abstract

There are no reliable markers useful to predict the onset or the evolution of chronic graft-versus-host disease (cGVHD) after allogeneic hematopoietic stem cell transplantation (HSCT), although several candidate biomarkers have been identified from limited hypothesis-driven studies. In this study we evaluated 14 patients who received a reduced intensity conditioning HSCT. Seven patients had cGVHD, whereas 7 never developed cGVHD during the period of observation. The expression of 114 cytokines in immunoselected cell populations was explored by microarray analysis and 11 cytokines were selected for further evaluation by real-time PCR. Differential gene expression measurements showed a significant up-regulation for INFγ (interferon, gamma) in CD8+ and for TNFSF3 (tumor necrosis factor superfamily, member 3) and for TNFSF10 (tumor necrosis factor superfamily, member 10) in CD14+ cell population when comparing cGVHD with control samples. The expression levels were significantly decreased for TNFSF10 in CD8+ cell population and for TNFSF12 (tumor necrosis factor superfamily, member 12) and for PDGFβ (platelet-derived growth factor, beta) in CD4+. Our data seem to suggest that different immune populations can play a role in cGVHD pathogenesis and the early detection of gene expression profile in these patients could be useful in the monitoring of GVHD. We hypothesized that PDGFβ down-regulation could represent a negative feedback to compensate for enhanced expression of its receptor recently reported.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21211989     DOI: 10.1016/j.cyto.2010.12.008

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  7 in total

1.  Gene expression profiling-based identification of CD28 and PI3K as new biomarkers for chronic graft-versus-host disease.

Authors:  Peilong Lai; Jianyu Weng; Zesheng Lu; Rong Guo; Chenwei Luo; Suijing Wu; Wei Ling; Suxia Geng; Xin Du
Journal:  DNA Cell Biol       Date:  2011-06-17       Impact factor: 3.311

2.  Identification of gene microarray expression profiles in patients with chronic graft-versus-host disease following allogeneic hematopoietic cell transplantation.

Authors:  Holbrook E Kohrt; Lu Tian; Li Li; Ash A Alizadeh; Sue Hsieh; Robert J Tibshirani; Samuel Strober; Minnie Sarwal; Robert Lowsky
Journal:  Clin Immunol       Date:  2013-05-01       Impact factor: 3.969

Review 3.  Biologic markers of chronic GVHD.

Authors:  J Pidala; M Sarwal; S Roedder; S J Lee
Journal:  Bone Marrow Transplant       Date:  2013-07-22       Impact factor: 5.483

4.  Plasmacytoid dendritic cells suppress HIV-1 replication but contribute to HIV-1 induced immunopathogenesis in humanized mice.

Authors:  Guangming Li; Menglan Cheng; Jun-Ichi Nunoya; Liang Cheng; Haitao Guo; Haisheng Yu; Yong-Jun Liu; Lishan Su; Liguo Zhang
Journal:  PLoS Pathog       Date:  2014-07-31       Impact factor: 6.823

5.  Combined meta-analysis of systemic effects of allogeneic stem cell transplantation and systemic sclerosis.

Authors:  Dmitry N Grigoryev; Jignesh Dalal; Mara L Becker; Shui Q Ye
Journal:  BMC Hematol       Date:  2014-03-22

6.  A combined biomarker and clinical panel for chronic graft versus host disease diagnosis.

Authors:  Joseph Pidala; Tara K Sigdel; Anyou Wang; Sue Hsieh; Yoshi Inamoto; Paul J Martin; Mary Ed Flowers; John A Hansen; Stephanie J Lee; Minnie M Sarwal
Journal:  J Pathol Clin Res       Date:  2016-11-29

Review 7.  Genetic Association of Hematopoietic Stem Cell Transplantation Outcome beyond Histocompatibility Genes.

Authors:  Rihab Gam; Pranali Shah; Rachel E Crossland; Jean Norden; Anne M Dickinson; Ralf Dressel
Journal:  Front Immunol       Date:  2017-04-03       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.